Abstract

Prenatal screening of pregnant women for HIV is central to eliminating mother-to-child-transmission (MTCT) of HIV. While some countries in sub-Saharan Africa (SSA) have scaled up their prevention of MTCT programmes, ensuring a near-universal prenatal care HIV testing, and recording a significant reduction in new infection among children, several others have poor outcomes due to inadequate testing. We conducted a multi-country analysis of demographic and health surveys (DHS) to assess the coverage of HIV testing during pregnancy and also examine the factors associated with uptake. We analysed data of 64,933 women from 16 SSA countries with recent DHS datasets (2015-2018) using Stata version 16. Adjusted and unadjusted logistic regression models were used to examine correlates of prenatal care uptake of HIV testing. Statistical significance was set at p<0.05. Progress in scaling up of prenatal care HIV testing was uneven across SSA, with only 6.1% of pregnant women tested in Chad compared to 98.1% in Rwanda. While inequality in access to HIV testing among pregnant women is pervasive in most SSA countries and particularly in West and Central Africa sub-regions, a few countries, including Rwanda, South Africa, Zimbabwe, Malawi and Zambia have managed to eliminate wealth and rural-urban inequalities in access to prenatal care HIV testing. Our findings highlight the between countries and sub-regional disparities in prenatal care uptake of HIV testing in SSA. Even though no country has universal coverage of prenatal care HIV testing, East and Southern African regions have made remarkable progress towards ensuring no pregnant woman is left untested. However, the West and Central Africa regions had low coverage of prenatal care testing, with the rich and well educated having better access to testing, while the poor rarely tested. Addressing the inequitable access and coverage of HIV testing among pregnant women is vital in these sub-regions.

Highlights

  • With the introduction of antiretroviral treatments (ART), there has been a 40% decline in new HIV infections from 2.9 million in 1997 to 1.7 million in 2019 [1]

  • Progress in scaling up of prenatal care HIV testing was uneven across sub-Saharan Africa (SSA), with only 6.1% of pregnant women tested in Chad compared to 98.1% in Rwanda

  • While inequality in access to HIV testing among pregnant women is pervasive in most SSA countries and in West and Central Africa sub-regions, a few countries, including Rwanda, South Africa, Zimbabwe, Malawi and Zambia have managed to eliminate wealth and rural-urban inequalities in access to prenatal care HIV testing

Read more

Summary

Introduction

With the introduction of antiretroviral treatments (ART), there has been a 40% decline in new HIV infections from 2.9 million in 1997 to 1.7 million in 2019 [1]. With over 150,000 new infections among children in 2018, mother to child transmission of HIV (MTCT) remains a major public health concern [1]. 61% of global new infections among children in 2019 occurred among children in sub-Saharan Africa (SSA), with western and central African countries having the highest record of children infected [1]. While Southern and Eastern African countries such as Comoros, Malawi, Rwanda, South Africa, Burundi, and Uganda have seen a remarkable decline in MTCT transmission of HIV, many countries in West and Central Africa like Angola, Equatorial Guinea, the Gambia, Mali, and Niger have experienced an increase in transmission rate [2]. While some countries in sub-Saharan Africa (SSA) have scaled up their prevention of MTCT programmes, ensuring a near-universal prenatal care HIV testing, and recording a significant reduction in new infection among children, several others have poor outcomes due to inadequate testing.

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call